| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Neuropathy, Ischemic | 15 | 2024 | 87 | 4.340 |
Why?
|
| Visual Prosthesis | 9 | 2021 | 48 | 2.910 |
Why?
|
| Electric Stimulation | 24 | 2011 | 1743 | 2.860 |
Why?
|
| Retinal Ganglion Cells | 23 | 2023 | 811 | 2.570 |
Why?
|
| Blindness | 22 | 2023 | 587 | 2.390 |
Why?
|
| Retina | 27 | 2020 | 2661 | 2.320 |
Why?
|
| Electrodes, Implanted | 15 | 2020 | 841 | 2.050 |
Why?
|
| Giant Cell Arteritis | 7 | 2021 | 307 | 1.960 |
Why?
|
| Retinal Artery Occlusion | 7 | 2021 | 83 | 1.940 |
Why?
|
| Optic Neuritis | 12 | 2017 | 175 | 1.930 |
Why?
|
| Vision Disorders | 22 | 2023 | 1093 | 1.590 |
Why?
|
| Optic Nerve Diseases | 17 | 2023 | 342 | 1.550 |
Why?
|
| Retinal Diseases | 12 | 2024 | 710 | 1.290 |
Why?
|
| Microelectrodes | 14 | 2020 | 308 | 1.160 |
Why?
|
| Blepharoptosis | 2 | 2023 | 145 | 1.160 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 2 | 2017 | 8 | 1.140 |
Why?
|
| Action Potentials | 12 | 2011 | 1838 | 1.060 |
Why?
|
| Optic Disk | 14 | 2020 | 422 | 1.060 |
Why?
|
| Intracranial Hypertension | 4 | 2021 | 193 | 1.010 |
Why?
|
| Prosthesis Implantation | 8 | 2011 | 594 | 1.000 |
Why?
|
| Retinitis Pigmentosa | 5 | 2012 | 395 | 0.940 |
Why?
|
| Ophthalmic Artery | 3 | 2021 | 58 | 0.920 |
Why?
|
| Retinal Artery | 3 | 2021 | 109 | 0.910 |
Why?
|
| Vision, Ocular | 10 | 2021 | 458 | 0.900 |
Why?
|
| Temporal Arteries | 5 | 2015 | 155 | 0.900 |
Why?
|
| Ophthalmoplegia | 3 | 2023 | 168 | 0.870 |
Why?
|
| Sensory Thresholds | 7 | 2009 | 377 | 0.870 |
Why?
|
| Ocular Motility Disorders | 4 | 2017 | 144 | 0.860 |
Why?
|
| Tomography, Optical Coherence | 9 | 2024 | 2957 | 0.830 |
Why?
|
| Orbital Neoplasms | 4 | 2022 | 223 | 0.830 |
Why?
|
| Glucagon-Like Peptides | 1 | 2024 | 157 | 0.820 |
Why?
|
| Visual Fields | 19 | 2018 | 1067 | 0.800 |
Why?
|
| Optic Nerve | 11 | 2023 | 571 | 0.800 |
Why?
|
| Electric Stimulation Therapy | 6 | 2011 | 637 | 0.750 |
Why?
|
| Eye Neoplasms | 2 | 2022 | 306 | 0.750 |
Why?
|
| Evoked Potentials, Visual | 9 | 2009 | 420 | 0.740 |
Why?
|
| Adnexal Diseases | 1 | 2022 | 105 | 0.740 |
Why?
|
| Orbit | 2 | 2024 | 459 | 0.730 |
Why?
|
| Neurofibromatosis 1 | 2 | 2024 | 561 | 0.730 |
Why?
|
| Eye, Artificial | 2 | 2012 | 18 | 0.710 |
Why?
|
| Sex Reassignment Procedures | 1 | 2021 | 72 | 0.710 |
Why?
|
| Scotoma | 4 | 2017 | 128 | 0.670 |
Why?
|
| Vision, Monocular | 2 | 2017 | 71 | 0.660 |
Why?
|
| Retinal Vessels | 5 | 2021 | 864 | 0.660 |
Why?
|
| Intracranial Embolism | 1 | 2021 | 189 | 0.660 |
Why?
|
| Telemetry | 2 | 2011 | 200 | 0.630 |
Why?
|
| Intracranial Pressure | 1 | 2021 | 325 | 0.630 |
Why?
|
| Electroretinography | 15 | 2009 | 524 | 0.630 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 2 | 2017 | 50 | 0.630 |
Why?
|
| Prostheses and Implants | 7 | 2009 | 1279 | 0.610 |
Why?
|
| Coated Materials, Biocompatible | 4 | 2009 | 311 | 0.610 |
Why?
|
| Prosthesis Design | 7 | 2012 | 2126 | 0.600 |
Why?
|
| Diplopia | 4 | 2013 | 217 | 0.600 |
Why?
|
| Isaacs Syndrome | 1 | 2017 | 5 | 0.590 |
Why?
|
| Pseudotumor Cerebri | 2 | 2017 | 107 | 0.590 |
Why?
|
| Visual Acuity | 21 | 2021 | 2714 | 0.580 |
Why?
|
| Embolism | 1 | 2021 | 401 | 0.570 |
Why?
|
| Eye Diseases | 7 | 2004 | 658 | 0.560 |
Why?
|
| Abducens Nerve Diseases | 1 | 2017 | 44 | 0.560 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2021 | 708 | 0.560 |
Why?
|
| Deglutition Disorders | 1 | 2023 | 641 | 0.560 |
Why?
|
| Exotropia | 1 | 2017 | 64 | 0.550 |
Why?
|
| Hypotension | 1 | 2023 | 888 | 0.540 |
Why?
|
| GTP Phosphohydrolases | 2 | 2017 | 524 | 0.540 |
Why?
|
| Multiple Sclerosis | 5 | 2023 | 3250 | 0.530 |
Why?
|
| Choroid | 4 | 2024 | 363 | 0.520 |
Why?
|
| Videotape Recording | 1 | 2017 | 336 | 0.510 |
Why?
|
| Rabbits | 18 | 2011 | 4774 | 0.500 |
Why?
|
| Papilledema | 5 | 2010 | 130 | 0.490 |
Why?
|
| Choroidal Neovascularization | 1 | 2017 | 364 | 0.440 |
Why?
|
| Pituitary Gland | 1 | 2016 | 634 | 0.440 |
Why?
|
| Vision Tests | 4 | 2010 | 160 | 0.440 |
Why?
|
| Iridium | 2 | 2011 | 30 | 0.430 |
Why?
|
| Horner Syndrome | 1 | 2013 | 35 | 0.420 |
Why?
|
| Glaucoma, Open-Angle | 1 | 2019 | 742 | 0.420 |
Why?
|
| Subclavian Artery | 1 | 2013 | 138 | 0.400 |
Why?
|
| Differential Threshold | 2 | 2011 | 80 | 0.390 |
Why?
|
| Internationality | 2 | 2016 | 1008 | 0.390 |
Why?
|
| Oculomotor Muscles | 4 | 2010 | 405 | 0.390 |
Why?
|
| Visual Perception | 8 | 2016 | 1407 | 0.390 |
Why?
|
| Psychological Tests | 1 | 2014 | 642 | 0.380 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 3110 | 0.380 |
Why?
|
| Nervous System Diseases | 5 | 2004 | 1665 | 0.370 |
Why?
|
| Headache | 3 | 2018 | 1263 | 0.370 |
Why?
|
| GABA Antagonists | 1 | 2011 | 119 | 0.370 |
Why?
|
| Humans | 141 | 2024 | 768887 | 0.360 |
Why?
|
| Ciliary Arteries | 2 | 2021 | 19 | 0.360 |
Why?
|
| Biomedical Engineering | 2 | 2009 | 286 | 0.360 |
Why?
|
| Swine, Miniature | 4 | 2020 | 965 | 0.360 |
Why?
|
| Orbital Myositis | 2 | 2020 | 25 | 0.340 |
Why?
|
| Fluorescein Angiography | 7 | 2017 | 1086 | 0.340 |
Why?
|
| Aneurysm | 1 | 2013 | 343 | 0.330 |
Why?
|
| Advisory Committees | 1 | 2014 | 797 | 0.330 |
Why?
|
| Cluster Headache | 2 | 2020 | 54 | 0.330 |
Why?
|
| Nystagmus, Pathologic | 1 | 2010 | 104 | 0.330 |
Why?
|
| Awards and Prizes | 1 | 2013 | 365 | 0.330 |
Why?
|
| Implants, Experimental | 1 | 2009 | 99 | 0.320 |
Why?
|
| Materials Testing | 3 | 2009 | 873 | 0.320 |
Why?
|
| Microtechnology | 1 | 2009 | 70 | 0.320 |
Why?
|
| Eye Movements | 3 | 2010 | 514 | 0.310 |
Why?
|
| Neuromuscular Agents | 1 | 2010 | 148 | 0.310 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2009 | 122 | 0.310 |
Why?
|
| Arteritis | 3 | 2019 | 158 | 0.310 |
Why?
|
| Photic Stimulation | 7 | 2009 | 2003 | 0.300 |
Why?
|
| Ophthalmology | 2 | 2013 | 560 | 0.300 |
Why?
|
| Glucocorticoids | 7 | 2018 | 2167 | 0.300 |
Why?
|
| Ischemia | 4 | 2021 | 1900 | 0.280 |
Why?
|
| Animals | 39 | 2024 | 169408 | 0.280 |
Why?
|
| Sodium Channels | 1 | 2009 | 341 | 0.280 |
Why?
|
| Neuromyelitis Optica | 3 | 2017 | 266 | 0.270 |
Why?
|
| Visual Pathways | 5 | 2009 | 559 | 0.270 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2010 | 238 | 0.270 |
Why?
|
| Axons | 5 | 2012 | 1678 | 0.270 |
Why?
|
| Immunoglobulins, Intravenous | 2 | 2024 | 667 | 0.250 |
Why?
|
| Neurology | 1 | 2013 | 787 | 0.250 |
Why?
|
| Retinal Vein Occlusion | 2 | 1999 | 149 | 0.250 |
Why?
|
| Swine | 5 | 2020 | 5998 | 0.250 |
Why?
|
| Electrodes | 4 | 2011 | 617 | 0.250 |
Why?
|
| Nerve Net | 2 | 2008 | 2361 | 0.240 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2009 | 607 | 0.240 |
Why?
|
| Paraneoplastic Syndromes | 3 | 1997 | 154 | 0.230 |
Why?
|
| Biological Clocks | 1 | 2007 | 321 | 0.230 |
Why?
|
| Strabismus | 3 | 2010 | 320 | 0.230 |
Why?
|
| Reaction Time | 3 | 2006 | 2102 | 0.230 |
Why?
|
| Retinaldehyde | 1 | 2003 | 24 | 0.230 |
Why?
|
| Nerve Growth Factors | 1 | 2007 | 564 | 0.230 |
Why?
|
| Device Removal | 1 | 2009 | 643 | 0.230 |
Why?
|
| Retinal Degeneration | 2 | 2008 | 414 | 0.230 |
Why?
|
| Diagnosis, Differential | 14 | 2020 | 13020 | 0.220 |
Why?
|
| Hyperoxaluria | 1 | 2023 | 33 | 0.220 |
Why?
|
| Blood Patch, Epidural | 1 | 2003 | 57 | 0.220 |
Why?
|
| Biocompatible Materials | 3 | 2007 | 1703 | 0.220 |
Why?
|
| Semiconductors | 1 | 2004 | 98 | 0.210 |
Why?
|
| Chronotherapy | 1 | 2023 | 11 | 0.210 |
Why?
|
| Visual Field Tests | 5 | 2017 | 415 | 0.210 |
Why?
|
| Calcium Oxalate | 1 | 2023 | 75 | 0.210 |
Why?
|
| Mitochondria | 1 | 2016 | 3683 | 0.210 |
Why?
|
| Sneezing | 1 | 2002 | 17 | 0.200 |
Why?
|
| Membrane Potentials | 2 | 2005 | 1090 | 0.200 |
Why?
|
| Recovery of Function | 3 | 2018 | 2990 | 0.200 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 15 | 0.200 |
Why?
|
| Spinal Puncture | 3 | 2018 | 286 | 0.200 |
Why?
|
| Pregnancy Complications | 1 | 2016 | 2965 | 0.200 |
Why?
|
| Magnetic Resonance Angiography | 3 | 2021 | 1434 | 0.200 |
Why?
|
| Models, Neurological | 3 | 2010 | 1783 | 0.200 |
Why?
|
| Pupil Disorders | 1 | 2002 | 33 | 0.200 |
Why?
|
| Occipital Lobe | 1 | 2004 | 376 | 0.200 |
Why?
|
| Carotid Artery, Internal | 3 | 2021 | 445 | 0.190 |
Why?
|
| Acetazolamide | 2 | 2017 | 98 | 0.190 |
Why?
|
| Female | 67 | 2024 | 397464 | 0.190 |
Why?
|
| Tissue Engineering | 2 | 2009 | 1893 | 0.190 |
Why?
|
| Fundus Oculi | 8 | 2017 | 560 | 0.190 |
Why?
|
| Aged | 44 | 2024 | 171790 | 0.180 |
Why?
|
| Optic Nerve Neoplasms | 3 | 2009 | 45 | 0.180 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 251 | 0.180 |
Why?
|
| Nervous System Neoplasms | 1 | 2001 | 91 | 0.180 |
Why?
|
| Synaptic Transmission | 1 | 2007 | 1177 | 0.180 |
Why?
|
| Biopsy | 5 | 2016 | 6805 | 0.170 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 12252 | 0.170 |
Why?
|
| Intracranial Aneurysm | 2 | 2004 | 1293 | 0.170 |
Why?
|
| Foreign Bodies | 1 | 2024 | 403 | 0.170 |
Why?
|
| Male | 62 | 2024 | 365249 | 0.170 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2015 | 2831 | 0.170 |
Why?
|
| Central Nervous System | 1 | 2007 | 1345 | 0.170 |
Why?
|
| Intraocular Pressure | 4 | 2021 | 1304 | 0.170 |
Why?
|
| Autopsy | 1 | 2023 | 1013 | 0.170 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2000 | 354 | 0.170 |
Why?
|
| Middle Aged | 50 | 2024 | 223740 | 0.160 |
Why?
|
| Optic Nerve Injuries | 3 | 1999 | 150 | 0.160 |
Why?
|
| Light | 3 | 2007 | 1356 | 0.160 |
Why?
|
| Ocular Hypertension | 1 | 2020 | 211 | 0.160 |
Why?
|
| Adult | 54 | 2024 | 223818 | 0.150 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2023 | 36861 | 0.150 |
Why?
|
| Retrospective Studies | 15 | 2024 | 81892 | 0.150 |
Why?
|
| Optic Disk Drusen | 1 | 2017 | 38 | 0.140 |
Why?
|
| Subretinal Fluid | 1 | 2017 | 25 | 0.140 |
Why?
|
| Reading | 1 | 2021 | 543 | 0.140 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2017 | 92 | 0.140 |
Why?
|
| PC12 Cells | 2 | 2007 | 317 | 0.140 |
Why?
|
| Hemianopsia | 1 | 2018 | 121 | 0.140 |
Why?
|
| Autoimmune Diseases | 2 | 2024 | 2260 | 0.140 |
Why?
|
| Vision, Low | 2 | 2008 | 162 | 0.130 |
Why?
|
| Aging | 7 | 2023 | 8765 | 0.130 |
Why?
|
| Neural Prostheses | 1 | 2016 | 23 | 0.130 |
Why?
|
| Creutzfeldt-Jakob Syndrome | 1 | 2016 | 92 | 0.130 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2019 | 417 | 0.130 |
Why?
|
| MELAS Syndrome | 1 | 2016 | 56 | 0.130 |
Why?
|
| Neurosyphilis | 1 | 2016 | 27 | 0.130 |
Why?
|
| Visual Cortex | 3 | 2006 | 1112 | 0.130 |
Why?
|
| Neurites | 2 | 2009 | 390 | 0.130 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2009 | 3411 | 0.130 |
Why?
|
| Susac Syndrome | 1 | 2015 | 22 | 0.120 |
Why?
|
| Lyme Neuroborreliosis | 1 | 2016 | 50 | 0.120 |
Why?
|
| Equipment Failure Analysis | 2 | 2009 | 848 | 0.120 |
Why?
|
| Intravitreal Injections | 1 | 2017 | 401 | 0.120 |
Why?
|
| Optic Atrophies, Hereditary | 1 | 1995 | 27 | 0.120 |
Why?
|
| Electron Transport Complex I | 1 | 2016 | 153 | 0.120 |
Why?
|
| Glaucoma | 2 | 2021 | 1194 | 0.120 |
Why?
|
| Blood Vessels | 1 | 2020 | 1110 | 0.120 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2008 | 452 | 0.120 |
Why?
|
| Perceptual Disorders | 1 | 2016 | 199 | 0.120 |
Why?
|
| Artificial Intelligence | 1 | 2009 | 2665 | 0.120 |
Why?
|
| Oxidative Phosphorylation | 1 | 2016 | 501 | 0.120 |
Why?
|
| Neurons | 3 | 2009 | 9524 | 0.110 |
Why?
|
| Endoscopy | 1 | 2024 | 1862 | 0.110 |
Why?
|
| Pregnancy Trimester, Third | 1 | 2016 | 585 | 0.110 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 1995 | 119 | 0.110 |
Why?
|
| Acute Disease | 5 | 2017 | 7245 | 0.110 |
Why?
|
| DNA, Mitochondrial | 2 | 2017 | 871 | 0.110 |
Why?
|
| Antihypertensive Agents | 1 | 2023 | 2026 | 0.110 |
Why?
|
| Infarction | 1 | 1994 | 247 | 0.110 |
Why?
|
| Injections, Intramuscular | 2 | 2010 | 556 | 0.100 |
Why?
|
| Angiography | 1 | 2018 | 1598 | 0.100 |
Why?
|
| Cells, Cultured | 4 | 2011 | 19023 | 0.100 |
Why?
|
| Meningioma | 3 | 2009 | 1226 | 0.100 |
Why?
|
| Cerebrovascular Disorders | 3 | 2003 | 1486 | 0.100 |
Why?
|
| Electrophysiology | 4 | 2010 | 1266 | 0.100 |
Why?
|
| Meningeal Neoplasms | 3 | 2009 | 1258 | 0.100 |
Why?
|
| Melatonin | 3 | 2002 | 670 | 0.100 |
Why?
|
| Fourier Analysis | 1 | 2012 | 441 | 0.090 |
Why?
|
| Adrenal Cortex Hormones | 2 | 2015 | 1893 | 0.090 |
Why?
|
| Blood Flow Velocity | 3 | 2004 | 1376 | 0.090 |
Why?
|
| New York | 1 | 2013 | 884 | 0.090 |
Why?
|
| Amblyopia | 1 | 1993 | 152 | 0.090 |
Why?
|
| Retinal Vasculitis | 1 | 2011 | 46 | 0.090 |
Why?
|
| Equipment Design | 2 | 2009 | 3529 | 0.090 |
Why?
|
| Congresses as Topic | 1 | 2016 | 811 | 0.090 |
Why?
|
| Drug Combinations | 1 | 2017 | 2088 | 0.090 |
Why?
|
| Ophthalmoscopes | 1 | 2010 | 21 | 0.090 |
Why?
|
| Histocytochemistry | 1 | 2011 | 699 | 0.090 |
Why?
|
| Young Adult | 7 | 2021 | 60110 | 0.090 |
Why?
|
| Retinal Neurons | 1 | 2010 | 67 | 0.090 |
Why?
|
| Vitrectomy | 2 | 2004 | 392 | 0.090 |
Why?
|
| Sarcoidosis | 1 | 2016 | 535 | 0.090 |
Why?
|
| Circadian Rhythm | 4 | 2007 | 2593 | 0.090 |
Why?
|
| Capillaries | 3 | 2020 | 756 | 0.080 |
Why?
|
| Electrochemistry | 1 | 2009 | 146 | 0.080 |
Why?
|
| Telecommunications | 1 | 2009 | 79 | 0.080 |
Why?
|
| Ethambutol | 1 | 2008 | 59 | 0.080 |
Why?
|
| Ankyrins | 1 | 2009 | 123 | 0.080 |
Why?
|
| Radioisotopes | 1 | 2010 | 517 | 0.080 |
Why?
|
| Carotid Artery Diseases | 1 | 1995 | 878 | 0.080 |
Why?
|
| Statistics as Topic | 1 | 2015 | 2359 | 0.080 |
Why?
|
| Polylysine | 1 | 2009 | 131 | 0.080 |
Why?
|
| Reactive Oxygen Species | 1 | 2016 | 2149 | 0.080 |
Why?
|
| Adenosine Triphosphate | 1 | 1995 | 2003 | 0.080 |
Why?
|
| Boston | 2 | 2012 | 9375 | 0.080 |
Why?
|
| Eye Movement Measurements | 1 | 2008 | 32 | 0.080 |
Why?
|
| Artifacts | 2 | 2011 | 1942 | 0.070 |
Why?
|
| Rats | 3 | 2011 | 23847 | 0.070 |
Why?
|
| Nystagmus, Optokinetic | 1 | 2007 | 31 | 0.070 |
Why?
|
| Conjunctiva | 1 | 2011 | 475 | 0.070 |
Why?
|
| Reflex, Pupillary | 1 | 2007 | 62 | 0.070 |
Why?
|
| Biophysics | 1 | 2009 | 379 | 0.070 |
Why?
|
| Brain Ischemia | 1 | 2021 | 3008 | 0.070 |
Why?
|
| Incidence | 2 | 2024 | 21545 | 0.070 |
Why?
|
| History, 21st Century | 1 | 2013 | 1575 | 0.070 |
Why?
|
| Collagen | 2 | 2021 | 2646 | 0.070 |
Why?
|
| Laurence-Moon Syndrome | 1 | 1986 | 9 | 0.070 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2017 | 2059 | 0.070 |
Why?
|
| Mutation | 5 | 2017 | 30266 | 0.070 |
Why?
|
| Motion Perception | 2 | 2009 | 379 | 0.070 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 915 | 0.070 |
Why?
|
| Nerve Fibers | 2 | 2017 | 709 | 0.070 |
Why?
|
| Visually Impaired Persons | 1 | 2007 | 79 | 0.070 |
Why?
|
| Electromyography | 2 | 2010 | 1402 | 0.070 |
Why?
|
| 2-Amino-5-phosphonovalerate | 1 | 2006 | 57 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2009 | 20244 | 0.070 |
Why?
|
| Risk Factors | 3 | 2024 | 74971 | 0.070 |
Why?
|
| Anesthetics, Local | 2 | 2004 | 1004 | 0.070 |
Why?
|
| Patch-Clamp Techniques | 1 | 2009 | 927 | 0.070 |
Why?
|
| Spasm | 1 | 1986 | 131 | 0.070 |
Why?
|
| Lactates | 1 | 2007 | 401 | 0.070 |
Why?
|
| Surface Properties | 1 | 2009 | 1169 | 0.070 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2017 | 3518 | 0.070 |
Why?
|
| Optic Atrophy | 1 | 1986 | 79 | 0.070 |
Why?
|
| Excitatory Amino Acid Agonists | 1 | 2006 | 142 | 0.060 |
Why?
|
| Genetic Testing | 2 | 2017 | 3590 | 0.060 |
Why?
|
| Prospective Studies | 6 | 2023 | 54950 | 0.060 |
Why?
|
| Pigment Epithelium of Eye | 1 | 2006 | 209 | 0.060 |
Why?
|
| Eye Injuries | 1 | 2009 | 227 | 0.060 |
Why?
|
| Dysautonomia, Familial | 1 | 1986 | 94 | 0.060 |
Why?
|
| Radiotherapy, Conformal | 1 | 2009 | 549 | 0.060 |
Why?
|
| History, 20th Century | 1 | 2013 | 2771 | 0.060 |
Why?
|
| Homeostasis | 1 | 2016 | 3348 | 0.060 |
Why?
|
| Gadolinium | 1 | 2010 | 965 | 0.060 |
Why?
|
| Gold | 1 | 2009 | 488 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 1 | 2018 | 2171 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2007 | 945 | 0.060 |
Why?
|
| Blast Injuries | 1 | 2009 | 324 | 0.060 |
Why?
|
| Lacrimal Apparatus | 1 | 1987 | 223 | 0.060 |
Why?
|
| Radiography | 2 | 2012 | 6991 | 0.060 |
Why?
|
| Beak | 1 | 2024 | 10 | 0.060 |
Why?
|
| Mice | 5 | 2023 | 82074 | 0.060 |
Why?
|
| Chronic Disease | 1 | 2019 | 9384 | 0.060 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2006 | 247 | 0.060 |
Why?
|
| Antigens, CD | 1 | 2015 | 4032 | 0.060 |
Why?
|
| Feasibility Studies | 2 | 2009 | 5323 | 0.060 |
Why?
|
| Electric Conductivity | 1 | 2005 | 408 | 0.060 |
Why?
|
| Macular Degeneration | 1 | 2012 | 1016 | 0.060 |
Why?
|
| Quinoxalines | 1 | 2006 | 297 | 0.060 |
Why?
|
| Laser-Doppler Flowmetry | 1 | 2004 | 238 | 0.060 |
Why?
|
| Neurons, Afferent | 1 | 2006 | 498 | 0.060 |
Why?
|
| Gene Transfer Techniques | 1 | 2009 | 1209 | 0.060 |
Why?
|
| Blood Circulation | 1 | 2004 | 248 | 0.050 |
Why?
|
| Animals, Newborn | 1 | 2009 | 2695 | 0.050 |
Why?
|
| Awareness | 1 | 2007 | 653 | 0.050 |
Why?
|
| Foreign-Body Reaction | 1 | 2004 | 156 | 0.050 |
Why?
|
| Calcium | 1 | 2016 | 5792 | 0.050 |
Why?
|
| Nervous System | 1 | 1986 | 547 | 0.050 |
Why?
|
| Green Fluorescent Proteins | 1 | 2009 | 2067 | 0.050 |
Why?
|
| Immunosuppressive Agents | 2 | 2015 | 4207 | 0.050 |
Why?
|
| Quality of Life | 3 | 2021 | 13510 | 0.050 |
Why?
|
| Needlestick Injuries | 1 | 2003 | 71 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2021 | 22294 | 0.050 |
Why?
|
| Nerve Regeneration | 1 | 2009 | 799 | 0.050 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2005 | 265 | 0.050 |
Why?
|
| Tetrodotoxin | 1 | 2004 | 245 | 0.050 |
Why?
|
| Orientation | 1 | 2004 | 320 | 0.050 |
Why?
|
| Hematopoiesis, Extramedullary | 1 | 2002 | 53 | 0.050 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2004 | 877 | 0.050 |
Why?
|
| Injections, Epidural | 1 | 2003 | 203 | 0.050 |
Why?
|
| Computer-Aided Design | 1 | 2004 | 296 | 0.050 |
Why?
|
| Neoplasms, Germ Cell and Embryonal | 1 | 1987 | 493 | 0.050 |
Why?
|
| Microscopy, Polarization | 1 | 2021 | 88 | 0.050 |
Why?
|
| Carcinoma | 1 | 2013 | 2340 | 0.050 |
Why?
|
| Phacoemulsification | 1 | 2003 | 151 | 0.050 |
Why?
|
| Eye Injuries, Penetrating | 1 | 2003 | 121 | 0.050 |
Why?
|
| Polyethylene Glycols | 1 | 2007 | 1197 | 0.050 |
Why?
|
| Hydrogels | 1 | 2007 | 745 | 0.050 |
Why?
|
| False Positive Reactions | 1 | 2003 | 963 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 234 | 0.050 |
Why?
|
| Regional Blood Flow | 1 | 2004 | 1502 | 0.050 |
Why?
|
| Clinical Trials as Topic | 2 | 2007 | 8055 | 0.050 |
Why?
|
| Precipitating Factors | 1 | 2020 | 51 | 0.040 |
Why?
|
| Aged, 80 and over | 13 | 2016 | 59738 | 0.040 |
Why?
|
| Apoptosis | 1 | 2016 | 9528 | 0.040 |
Why?
|
| Eye Burns | 1 | 2000 | 64 | 0.040 |
Why?
|
| Pattern Recognition, Visual | 5 | 2008 | 826 | 0.040 |
Why?
|
| Polycythemia Vera | 1 | 2002 | 160 | 0.040 |
Why?
|
| Intraoperative Complications | 1 | 1987 | 1176 | 0.040 |
Why?
|
| Injections | 1 | 2003 | 841 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 2 | 2009 | 22381 | 0.040 |
Why?
|
| Antitubercular Agents | 1 | 2008 | 1397 | 0.040 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 8200 | 0.040 |
Why?
|
| Neuronal Plasticity | 2 | 2007 | 1449 | 0.040 |
Why?
|
| Computer Simulation | 3 | 2010 | 6289 | 0.040 |
Why?
|
| Military Personnel | 1 | 2009 | 1264 | 0.040 |
Why?
|
| Radiation Injuries | 1 | 1986 | 1203 | 0.040 |
Why?
|
| Sus scrofa | 1 | 2020 | 430 | 0.040 |
Why?
|
| Artificial Organs | 1 | 2000 | 149 | 0.040 |
Why?
|
| Models, Biological | 2 | 2011 | 9499 | 0.040 |
Why?
|
| Time Factors | 5 | 2006 | 40266 | 0.040 |
Why?
|
| Arteriosclerosis | 1 | 2003 | 1056 | 0.040 |
Why?
|
| Aneurysm, Ruptured | 1 | 2004 | 462 | 0.040 |
Why?
|
| Alzheimer Disease | 4 | 1994 | 8758 | 0.040 |
Why?
|
| Wounds, Nonpenetrating | 3 | 1999 | 807 | 0.040 |
Why?
|
| Cataract Extraction | 1 | 2002 | 465 | 0.040 |
Why?
|
| Organ Culture Techniques | 1 | 2000 | 796 | 0.040 |
Why?
|
| Adolescent | 14 | 2006 | 89247 | 0.040 |
Why?
|
| Follow-Up Studies | 7 | 2018 | 39394 | 0.040 |
Why?
|
| Albendazole | 1 | 1997 | 51 | 0.040 |
Why?
|
| Postoperative Complications | 3 | 2006 | 15889 | 0.040 |
Why?
|
| Photography | 3 | 1997 | 537 | 0.030 |
Why?
|
| Brain Injuries | 1 | 2009 | 2058 | 0.030 |
Why?
|
| Color Perception | 3 | 1994 | 213 | 0.030 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2003 | 783 | 0.030 |
Why?
|
| Myasthenia Gravis | 1 | 1999 | 217 | 0.030 |
Why?
|
| Thailand | 1 | 2017 | 288 | 0.030 |
Why?
|
| Remission, Spontaneous | 1 | 2017 | 385 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2021 | 1680 | 0.030 |
Why?
|
| Age Distribution | 1 | 2002 | 2875 | 0.030 |
Why?
|
| Cryptococcosis | 1 | 1997 | 103 | 0.030 |
Why?
|
| Smoking | 1 | 1993 | 9094 | 0.030 |
Why?
|
| Spinal Fusion | 1 | 2006 | 1313 | 0.030 |
Why?
|
| Cross-Sectional Studies | 2 | 2010 | 26384 | 0.030 |
Why?
|
| Optic Chiasm | 1 | 1996 | 91 | 0.030 |
Why?
|
| Muscle Fibers, Skeletal | 1 | 1999 | 553 | 0.030 |
Why?
|
| Syndrome | 3 | 2003 | 3274 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2005 | 3659 | 0.030 |
Why?
|
| Sensitivity and Specificity | 2 | 2009 | 14751 | 0.030 |
Why?
|
| Pregnancy | 2 | 2016 | 30175 | 0.030 |
Why?
|
| Patient Selection | 1 | 2007 | 4265 | 0.030 |
Why?
|
| Immunologic Factors | 1 | 2024 | 1597 | 0.030 |
Why?
|
| Candidiasis | 1 | 1997 | 367 | 0.030 |
Why?
|
| Glioma | 2 | 2001 | 3532 | 0.030 |
Why?
|
| Embolization, Therapeutic | 1 | 2004 | 1410 | 0.030 |
Why?
|
| Extracellular Matrix | 1 | 2021 | 1739 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2003 | 1558 | 0.030 |
Why?
|
| User-Computer Interface | 1 | 2000 | 1406 | 0.030 |
Why?
|
| Cerebral Arteries | 1 | 1996 | 489 | 0.030 |
Why?
|
| Brain | 4 | 2016 | 27476 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 2017 | 4123 | 0.030 |
Why?
|
| Lasers | 2 | 2003 | 952 | 0.030 |
Why?
|
| Hydroxocobalamin | 1 | 1993 | 27 | 0.030 |
Why?
|
| Nerve Compression Syndromes | 1 | 1995 | 160 | 0.030 |
Why?
|
| Decision Making | 1 | 2007 | 3952 | 0.030 |
Why?
|
| Genital Diseases, Female | 1 | 1994 | 192 | 0.030 |
Why?
|
| Choroid Diseases | 1 | 1993 | 63 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2008 | 14485 | 0.030 |
Why?
|
| Infant | 2 | 2008 | 36541 | 0.030 |
Why?
|
| Diagnostic Errors | 1 | 1999 | 1281 | 0.020 |
Why?
|
| Antifungal Agents | 1 | 1997 | 761 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2016 | 1836 | 0.020 |
Why?
|
| Eye | 1 | 2016 | 712 | 0.020 |
Why?
|
| Child, Preschool | 2 | 2008 | 42684 | 0.020 |
Why?
|
| Child | 5 | 2009 | 80969 | 0.020 |
Why?
|
| Photoreceptor Cells | 1 | 1992 | 234 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2004 | 4415 | 0.020 |
Why?
|
| Temporal Lobe | 1 | 1999 | 1728 | 0.020 |
Why?
|
| Health Services Accessibility | 1 | 2009 | 5520 | 0.020 |
Why?
|
| Managed Care Programs | 1 | 2016 | 941 | 0.020 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2024 | 20776 | 0.020 |
Why?
|
| Paclitaxel | 1 | 1998 | 1735 | 0.020 |
Why?
|
| Myelin Sheath | 1 | 1994 | 653 | 0.020 |
Why?
|
| Consensus | 1 | 2020 | 3214 | 0.020 |
Why?
|
| Double-Blind Method | 2 | 2002 | 12469 | 0.020 |
Why?
|
| Carcinoma, Small Cell | 1 | 1992 | 419 | 0.020 |
Why?
|
| Glaucoma, Neovascular | 1 | 1990 | 37 | 0.020 |
Why?
|
| Pelvis | 1 | 1994 | 738 | 0.020 |
Why?
|
| Cerebral Angiography | 1 | 1995 | 1272 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2004 | 3538 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2003 | 15471 | 0.020 |
Why?
|
| Age Factors | 4 | 2008 | 18454 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1992 | 1705 | 0.020 |
Why?
|
| Immunoglobulins | 1 | 1992 | 855 | 0.020 |
Why?
|
| Cavernous Sinus | 1 | 1990 | 122 | 0.020 |
Why?
|
| Oxygen | 1 | 2020 | 4273 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2008 | 18366 | 0.020 |
Why?
|
| DNA Copy Number Variations | 1 | 2017 | 2055 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2010 | 65485 | 0.020 |
Why?
|
| Mycobacterium avium-intracellulare Infection | 1 | 2008 | 82 | 0.020 |
Why?
|
| Brain Mapping | 1 | 2004 | 6740 | 0.020 |
Why?
|
| Autoantigens | 1 | 1992 | 891 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2017 | 2592 | 0.020 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 1987 | 23 | 0.020 |
Why?
|
| Electrooculography | 1 | 2007 | 113 | 0.020 |
Why?
|
| Glaucoma, Angle-Closure | 1 | 1990 | 192 | 0.020 |
Why?
|
| Cerebral Cortex | 1 | 2004 | 5834 | 0.020 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2008 | 203 | 0.020 |
Why?
|
| Arteriovenous Fistula | 1 | 1990 | 320 | 0.020 |
Why?
|
| Recurrence | 2 | 2015 | 8512 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2017 | 4784 | 0.020 |
Why?
|
| Prognosis | 4 | 2008 | 30044 | 0.020 |
Why?
|
| Ophthalmoscopy | 1 | 1986 | 172 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2013 | 21187 | 0.020 |
Why?
|
| Information Storage and Retrieval | 1 | 2011 | 831 | 0.020 |
Why?
|
| Photons | 1 | 2009 | 595 | 0.020 |
Why?
|
| Sleep Initiation and Maintenance Disorders | 1 | 1995 | 1106 | 0.020 |
Why?
|
| United States | 4 | 2017 | 73180 | 0.010 |
Why?
|
| Cerebral Hemorrhage | 1 | 1996 | 2660 | 0.010 |
Why?
|
| Chondrosarcoma | 1 | 1986 | 306 | 0.010 |
Why?
|
| Craniopharyngioma | 1 | 1986 | 279 | 0.010 |
Why?
|
| Cohort Studies | 2 | 2017 | 41800 | 0.010 |
Why?
|
| Rhabdomyosarcoma | 1 | 1986 | 358 | 0.010 |
Why?
|
| Infusions, Intravenous | 2 | 1999 | 2231 | 0.010 |
Why?
|
| United States Department of Veterans Affairs | 1 | 2009 | 941 | 0.010 |
Why?
|
| Birefringence | 1 | 2003 | 54 | 0.010 |
Why?
|
| Electromagnetic Fields | 1 | 2005 | 289 | 0.010 |
Why?
|
| Proteins | 1 | 2017 | 6011 | 0.010 |
Why?
|
| Radiotherapy Dosage | 1 | 2009 | 2920 | 0.010 |
Why?
|
| Regression Analysis | 1 | 1991 | 6346 | 0.010 |
Why?
|
| Neural Conduction | 1 | 2003 | 443 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2016 | 12563 | 0.010 |
Why?
|
| Continuity of Patient Care | 1 | 2009 | 1076 | 0.010 |
Why?
|
| Smoking Cessation | 1 | 1993 | 2084 | 0.010 |
Why?
|
| Lens Implantation, Intraocular | 1 | 2003 | 192 | 0.010 |
Why?
|
| Cell Count | 1 | 2005 | 1833 | 0.010 |
Why?
|
| Hip Prosthesis | 1 | 1987 | 924 | 0.010 |
Why?
|
| Spinal Diseases | 1 | 2006 | 563 | 0.010 |
Why?
|
| Anesthesia, Local | 1 | 2003 | 279 | 0.010 |
Why?
|
| Synapses | 1 | 2010 | 1766 | 0.010 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2003 | 251 | 0.010 |
Why?
|
| Biological Availability | 1 | 2001 | 392 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 2017 | 7885 | 0.010 |
Why?
|
| Life Expectancy | 1 | 1986 | 1249 | 0.010 |
Why?
|
| Brain Neoplasms | 2 | 1998 | 9213 | 0.010 |
Why?
|
| Hypertrophy | 1 | 2001 | 562 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2004 | 2342 | 0.010 |
Why?
|
| Maximum Tolerated Dose | 1 | 2001 | 899 | 0.010 |
Why?
|
| Antineoplastic Agents | 1 | 2001 | 13699 | 0.010 |
Why?
|
| Drug Eruptions | 1 | 2001 | 335 | 0.010 |
Why?
|
| Coronary Artery Bypass | 1 | 1987 | 2194 | 0.010 |
Why?
|
| Age of Onset | 1 | 2005 | 3346 | 0.010 |
Why?
|
| Haplotypes | 1 | 2004 | 2725 | 0.010 |
Why?
|
| Evoked Potentials | 1 | 2004 | 1058 | 0.010 |
Why?
|
| Head Injuries, Closed | 1 | 1999 | 133 | 0.010 |
Why?
|
| Facial Paralysis | 1 | 2002 | 346 | 0.010 |
Why?
|
| Atrophy | 1 | 2003 | 1647 | 0.010 |
Why?
|
| Craniocerebral Trauma | 2 | 1994 | 495 | 0.010 |
Why?
|
| Phenotype | 2 | 2004 | 16735 | 0.010 |
Why?
|
| Disease Progression | 2 | 2008 | 13677 | 0.010 |
Why?
|
| Fibrosis | 1 | 2004 | 2081 | 0.010 |
Why?
|
| Reoperation | 1 | 1987 | 4342 | 0.010 |
Why?
|
| Mice, Inbred ICR | 1 | 1997 | 363 | 0.010 |
Why?
|
| Cochlea | 1 | 2003 | 848 | 0.010 |
Why?
|
| Pain | 1 | 1991 | 5100 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 4545 | 0.010 |
Why?
|
| Cryptococcus neoformans | 1 | 1997 | 121 | 0.010 |
Why?
|
| Fingers | 1 | 1999 | 512 | 0.010 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1986 | 3782 | 0.010 |
Why?
|
| Monitoring, Intraoperative | 1 | 2002 | 950 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1991 | 8541 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2001 | 2862 | 0.010 |
Why?
|
| Task Performance and Analysis | 1 | 1999 | 771 | 0.010 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 6085 | 0.010 |
Why?
|
| Homeodomain Proteins | 1 | 2004 | 2431 | 0.010 |
Why?
|
| Body Temperature | 1 | 1998 | 781 | 0.010 |
Why?
|
| Flicker Fusion | 1 | 1994 | 14 | 0.010 |
Why?
|
| Diarrhea | 1 | 2001 | 1319 | 0.010 |
Why?
|
| Candida albicans | 1 | 1997 | 375 | 0.010 |
Why?
|
| Vestibular Function Tests | 1 | 1994 | 128 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2000 | 2269 | 0.010 |
Why?
|
| Decompression, Surgical | 1 | 1999 | 610 | 0.010 |
Why?
|
| Administration, Oral | 1 | 2001 | 4042 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2001 | 6242 | 0.010 |
Why?
|
| Tyrosine 3-Monooxygenase | 1 | 1993 | 370 | 0.010 |
Why?
|
| Head and Neck Neoplasms | 1 | 1986 | 2931 | 0.010 |
Why?
|
| Neoplasms | 1 | 2001 | 22390 | 0.010 |
Why?
|
| Amines | 1 | 1993 | 280 | 0.010 |
Why?
|
| Color Perception Tests | 1 | 1991 | 12 | 0.010 |
Why?
|
| Neurologic Examination | 1 | 1994 | 916 | 0.010 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1997 | 1963 | 0.010 |
Why?
|
| Anthropometry | 1 | 1995 | 1343 | 0.010 |
Why?
|
| Gonioscopy | 1 | 1990 | 157 | 0.010 |
Why?
|
| Anterior Chamber | 1 | 1990 | 194 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 10778 | 0.000 |
Why?
|
| Contrast Sensitivity | 1 | 1991 | 253 | 0.000 |
Why?
|
| Iris | 1 | 1990 | 231 | 0.000 |
Why?
|
| Costs and Cost Analysis | 1 | 1994 | 1669 | 0.000 |
Why?
|
| Anticonvulsants | 1 | 1998 | 1924 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 1992 | 13593 | 0.000 |
Why?
|
| Immunohistochemistry | 1 | 2001 | 11119 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2008 | 18065 | 0.000 |
Why?
|
| Indoles | 1 | 1993 | 1836 | 0.000 |
Why?
|
| Retinal Detachment | 1 | 1990 | 429 | 0.000 |
Why?
|
| Postoperative Period | 1 | 1990 | 1830 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2004 | 12174 | 0.000 |
Why?
|
| Survival Rate | 1 | 1998 | 12873 | 0.000 |
Why?
|
| Epilepsy | 1 | 1999 | 3326 | 0.000 |
Why?
|
| Laser Therapy | 1 | 1990 | 1110 | 0.000 |
Why?
|
| Laparoscopy | 1 | 1994 | 2055 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 1994 | 5544 | 0.000 |
Why?
|
| Ultrasonography | 1 | 1990 | 6001 | 0.000 |
Why?
|